In a blow to tens of thousands of Brits, draft guidance by the NHS spending watchdog ruled the benefits of the drug are far too small to justify the roll-out cost.
Source link : https://www.dailymail.co.uk/health/article-13991125/patients-drug-donanemab-Alzheimers-treatment-NHS-watchdog.html?ns_mchannel=rss&ito=1490&ns_campaign=1490
Author :
Publish date : 2024-10-23 09:57:01
Copyright for syndicated content belongs to the linked Source.
Anger as NHS patients told they WON’T get ‘new hope’ Alzheimer’s drug donanemab
TOBIAS ELLWOOD: Putin’s hypersonic missile attack in Ukraine should serve as a resounding wake-up call
Young women killed in Laos methanol poisoning are identified as death toll rises to six – as heartbreaking photograph of South East Asia trip emerges
